AR and neoplasm: Luminal androgen receptor (LAR) tumours are characterised by high expression of androgen receptor (AR) and downstream AR targets, and enrichment of pathways involved in steroid synthesis, porphyrin metabolism, and androgen/oestrogen metabolism (18).